Professor Simon Skene
Prof Skene has over 20 years’ experience as a medical statistician in teaching and research, including the design and analysis of studies investigating medicinal products, advanced therapies, diagnostic accuracy and surgery. His PhD focused on the analysis of very small samples of repeated measurements, addressing small sample issues in longitudinal analysis. He is a Fellow of the Royal Statistical Society and has consultancy experience in the pharmaceutical industry.
As Head of Statistics at the UCL Comprehensive Clinical Trials Unit, he provided leadership and statistical oversight on UK trials coordinated by the unit across phases I-III in multiple therapeutic areas including hepatology and gastroenterology, ophthalmology, neurology and surgery.
Prof Skene's appointment at University of Surrey combines the role of Director of the Clinical Trials Unit (CTU) and Clinical Research Facility (CRF) with leadership in statistics to support decision based practice in medicine. He is additionally Head of Department of Clinical and Experimental Medicine which brings together the CTU, CRF and Surrey Sleep Research Centre (SSRC) with complementary sections comprising Research Design Service - South East (RDS SE; Surrey Hub), Surrey Health Economics Centre (SHEC), Clinical Medicine and Statistical Multi-Omics. The department is dedicated to academic excellence in education and the delivery of clinical research in health and disease.
View Prof Skene's academic profile here.
Dr Agnieszka Michael MBBS PhD MRCP
Dr Michael qualified in medicine from Wroclaw University in Poland in 1994 and received a doctorate in cancer gene therapy from St George’s, University of London in 2006. She trained in Medical Oncology at the Royal Marsden Hospital, St George’s Hospital, London, and Guys and Thomas’s Hospital. She has been working at the University of Surrey since 2008, and is a Clinical Reader in Medical Oncology. She also works as a Consultant Medical Oncologist at the Royal Surrey County Hospital. Dr Michael’s key research specialities are in the areas of Ovarian Cancer and urological malignancies .
Dr Michael is a member of NCRN Clinical Studies Group for Gynaecological Cancers and has experience in running national and international clinical trials for new cancer treatments as a local Principal Investigator and a UK Chief Investigator. She has recently been successful in obtaining CTAAC/CRUK approval for a new investigator-driven multi-centre study of a TroVax vaccine in ovarian cancer (TRIOC) which is due to run in 10 centres in UK. Dr Michael also supervises a number of translational sciences projects, mainly in gynaecological cancers and has set up a tissue bank based at at the University of Surrey, which is now become a part of the NCRI on Core UK-Confederation of Cancer Biobanks (CCB).
View Dr Michael's academic profile here.